AKT1 and thyroid cancer: These genetic mutations can deregulate the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K)/AKT signalling pathways which are crucial to the pathogenesis of thyroid cancer [11].